INTEGRA LIFESCIENCES HOLDINGS CORP Net Cash Provided by (Used in) Investing Activities, Continuing Operations
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.22 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-03-01
- INTEGRA LIFESCIENCES HOLDINGS CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$21.14M.
- INTEGRA LIFESCIENCES HOLDINGS CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$6.71M.
- INTEGRA LIFESCIENCES HOLDINGS CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$8.04M.
- INTEGRA LIFESCIENCES HOLDINGS CORP net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was -$6.73M.
- INTEGRA LIFESCIENCES HOLDINGS CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$1.22B.
- INTEGRA LIFESCIENCES HOLDINGS CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$42.62M.
- INTEGRA LIFESCIENCES HOLDINGS CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$364.95M.
- INTEGRA LIFESCIENCES HOLDINGS CORP net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$359.74M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$1.22B 10-K · filed 2018-03-01 | |||
| 2016-12-31 | -$21.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$27.85M derived: sum of 2 quarters · filed 2018-03-01 | -$35.89M derived: sum of 3 quarters · filed 2018-03-01 | -$42.62M 10-K · filed 2018-03-01 |
| 2016-09-30 | -$6.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$14.75M derived: sum of 2 quarters · filed 2016-10-28 | -$21.48M 10-Q · filed 2016-10-28 | -$59.30M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | -$8.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$14.77M 10-Q · filed 2016-07-28 | -$52.59M derived: sum of 3 quarters · filed 2018-03-01 | -$368.04M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | -$6.73M 10-Q · filed 2016-04-27 | -$44.55M derived: sum of 2 quarters · filed 2018-03-01 | -$360.00M derived: sum of 3 quarters · filed 2018-03-01 | -$369.62M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | -$37.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$353.27M derived: sum of 2 quarters · filed 2018-03-01 | -$362.89M derived: sum of 3 quarters · filed 2018-03-01 | -$364.95M 10-K · filed 2018-03-01 |
| 2015-09-30 | -$315.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$325.07M derived: sum of 2 quarters · filed 2016-10-28 | -$327.13M 10-Q · filed 2016-10-28 | -$424.76M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | -$9.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$11.68M 10-Q · filed 2016-07-28 | -$109.31M derived: sum of 3 quarters · filed 2017-02-23 | |
| 2015-03-31 | -$2.06M 10-Q · filed 2016-04-27 | -$99.69M derived: sum of 2 quarters · filed 2017-02-23 | ||
| 2014-12-31 | -$97.63M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$359.74M 10-K · filed 2017-02-23 | ||
| 2014-09-30 | -$262.11M 10-Q · filed 2015-11-04 | |||
| 2013-12-31 | -$44.75M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |